{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:22:08Z","timestamp":1783650128084,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vph.2009.04.002","type":"journal-article","created":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T13:00:46Z","timestamp":1240318846000},"page":"90-95","source":"Crossref","is-referenced-by-count":26,"title":["Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?"],"prefix":"10.1016","volume":"51","author":[{"given":"T.H.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.P.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vph.2009.04.002_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.vph.2009.04.002_bib2","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.vph.2009.04.002_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.vph.2009.04.002_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.vph.2009.04.002_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.vph.2009.04.002_bib6","article-title":"National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland","volume":"63","author":"Gibbs","year":"2008","journal-title":"Thorax"},{"issue":"12 Suppl S","key":"10.1016\/j.vph.2009.04.002_bib7","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2009.04.002_bib8","doi-asserted-by":"crossref","first-page":"L1366","DOI":"10.1152\/ajplung.00273.2001","article-title":"Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation","volume":"282","author":"Jernigan","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2009.04.002_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.vph.2006.01.013","article-title":"A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease","volume":"44","author":"Madden","year":"2006","journal-title":"Vascul. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.vph.2009.04.002_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vph.2007.06.003","article-title":"Does sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?","volume":"47","author":"Madden","year":"2007","journal-title":"Vascul. Pharmacol."},{"issue":"27","key":"10.1016\/j.vph.2009.04.002_bib11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2009.04.002_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.vph.2009.04.002_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.vph.2009.04.002_bib14","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group","year":"2005","journal-title":"N. Engl. J. Med."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T10:25:42Z","timestamp":1545301542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189109000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":14,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1537189109000445"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2009.04.002","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}